Request Trial
Bobby Mukherjee, chief counsel, IP & Technology Law at BAE Systems and now immediate past president of the Chartered Institute of Patent Attorneys
7 January 2026NewsEuropeSarah Speight

CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’

As he hands over the baton, Bobby Mukherjee reflects on his time leading the Chartered Institute of Patent Attorneys—from progressing the soon-to-be-launched paid apprenticeship schemes to engaging with the UK body’s in-house members. Sarah Speight reports.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026   A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.
Europe
Italian medtech startup beats larger US rival in UPC dispute
15 January 2026   Case between AorticLab and Emboline has implications for UPC playbook in terms of requesting security for costs, and conditional counterclaims.
Europe
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
13 January 2026   As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.


Editor's picks

The quantum advantage: IP considerations for the next generation of life sciences innovation
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026

Editor's picks

Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025

More features

The quantum advantage: IP considerations for the next generation of life sciences innovation
Fed Circ overturns PTAB decision in $83.4m DNA case
Simpson Thacher adds ‘exemplary’ litigator with emerging tech expertise
AI is transforming top 100 innovators, shows index
Novartis win blocks generics relitigating $7.8bn heart drug patent
Leading the arena: WIPR identifies the top US trade secrets specialists of 2025
Cadwalader global head among trio moving to Orrick
Skinny labels, big stakes: SCOTUS lines up the case of the year